Search Results

Results for "Máy ti"

FNIH Biomarkers Consortium and Critical Path Institute Achieve the First Ever Qualification of a Clinical Safety Biomarker by the U.S. Food and Drug Administration

Major Milestone will Improve Detection of Drug-Induced Acute Kidney Injury in Clinical Trials. October 25, 2018 —

UA Colleges of Law and Pharmacy, Critical Path Institute, Launch Graduate Certificate Program in Regulatory Science

Designed for graduate students and working professionals, the certificate program provides specialized training in navigating the

Evidence-Based Treatment Decisions In Transplantation: The Right Dose & Regimen for the Right Patient/Individualized Treatment

The following originally appeared on fda.gov: Summary: The Food and Drug Administration is announcing the following public worksho

First-ever biomarker qualified for Parkinson’s is a vital step toward improved clinical trials

FOR IMMEDIATE RELEASE Contact: Kissy Black 615.298.1144 kissyblack@lotosnile.com Tucson, AZ — July 26, 2018 – The Criti

New Collaboration Seeks to Speed Huntington’s Disease Drug Licensing

This article originally appeared on HDBuzz and is reprinted here under Creative Commons license. Critical Path Institute launches

May 10, 2018

Training on the Use of Technology to Collect Patient-Reported Outcome Data Electronically in Clinical Trials: Best Practice Recommendations from the ePRO Consortium (May 10, 2018)

This webinar provides a recommended framework for training end users, including site staff and study participants, on the use of e

C-Path Receives COA Qualification from FDA for the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)

TUCSON, Ariz. – May 7, 2018 — Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium annou

CPTR Newsletter – April 2018

CPTR Newsletter – April 2018 In this issue: ReSeqTB to be Adopted for WHO Surveillance of Drug-Resistant TB New Collabora

Critical Path to TB Drug Regimens (CPTR) 2018 Annual Workshop, postponed

Critical Path Institute and Bill & Melinda Gates Foundation have decided to postpone the Critical Path to TB Drug Regimens Wor

Critical Path Institute Receives Regulatory Support for Liver Injury Biomarker

Tucson, AZ — January 22, 2018 — Critical Path Institute (C-Path) announced today that the European Medicines Agency (E

Previous1718 19...24 Next